Envista (NYSE:NVST) Reaches New 1-Year High on Better-Than-Expected Earnings

Envista Holdings Corporation (NYSE:NVST) shares reached a new 52-week high during mid-day trading on Friday after the company announced better than expected quarterly earnings. The stock traded as high as $28.80 and last traded at $28.5230, with a volume of 994454 shares traded. The stock had previously closed at $24.71.

The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.55% and a net margin of 1.73%.The firm had revenue of $750.60 million during the quarter, compared to analysts’ expectations of $680.26 million. During the same quarter in the prior year, the firm posted $0.24 EPS. The company’s revenue for the quarter was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS.

Envista News Roundup

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q4 results beat expectations — Envista reported $0.38 EPS vs. $0.32 consensus and revenue of $750.6M versus ~ $680M est., with revenue up ~15% year-over-year. Strong results are the primary driver of the move higher. Envista Reports Fourth Quarter 2025 Results
• Positive Sentiment: Management raised FY‑2026 EPS guidance to $1.35–$1.45 vs. consensus ~ $1.27 — the stronger outlook (and beat + guidance combo) is supportive of the rally and suggests better-than-expected near-term growth. Press Release / Slide Deck
• Neutral Sentiment: Earnings materials and call transcripts are available for deeper read — the conference call transcript and slide deck provide management commentary on drivers (product mix, geographic trends, margins) that investors should review to judge sustainability. Earnings Call Transcript Earnings Presentation
• Neutral Sentiment: Wall‑street writeups and snapshots (Zacks, Yahoo, Investing) highlight the beat and value/Growth characteristics — useful for screening but not new catalysts by themselves. Zacks Q4 Metrics
• Negative Sentiment: Analyst targets still imply downside — JPMorgan and Wells Fargo both raised targets to $26 but kept neutral/equal‑weight ratings; those $26 targets sit below the current market level, which could cap upside or prompt caution once headline momentum fades. Benzinga – JPMorgan Benzinga – Wells Fargo

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Wells Fargo & Company increased their price objective on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a research note on Friday. Evercore reissued an “outperform” rating and issued a $32.00 price target on shares of Envista in a research report on Friday. JPMorgan Chase & Co. raised their price target on shares of Envista from $22.00 to $26.00 and gave the stock a “neutral” rating in a research note on Friday. Barclays assumed coverage on Envista in a research note on Monday, December 8th. They issued an “overweight” rating and a $24.00 price objective on the stock. Finally, Leerink Partners set a $35.00 target price on Envista and gave the stock an “outperform” rating in a research report on Friday. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Envista presently has an average rating of “Hold” and a consensus target price of $26.50.

Institutional Investors Weigh In On Envista

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC boosted its stake in Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after purchasing an additional 1,026 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after buying an additional 1,504 shares during the last quarter. Allworth Financial LP lifted its position in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares during the last quarter. Finally, IFP Advisors Inc increased its position in Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares in the last quarter.

Envista Stock Performance

The company has a market capitalization of $4.80 billion, a P/E ratio of 104.18, a P/E/G ratio of 1.29 and a beta of 1.01. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.37 and a quick ratio of 2.02. The stock’s 50 day simple moving average is $22.80 and its two-hundred day simple moving average is $21.24.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.